Results 241 to 250 of about 70,680 (286)

Protectin D1 and maresin 1 attenuate airway hyperreactivity induced by IL‐13 in human isolated small bronchi

open access: yesBritish Journal of Pharmacology, EarlyView.
Background and Purpose Interleukin (IL)‐13 is implicated in airway hyperreactivity (AHR), a key feature of asthma. We explored the potential anti‐AHR activity of selected specialised pro‐resolving mediators (SPMs) in IL‐13‐induced AHR models, using human bronchial smooth muscle cells (BSMCs) and human isolated bronchi.
Willem Abma   +9 more
wiley   +1 more source

Machine Learning-Enabled Image Comparability Assessment for Flow Imaging Microscopy Across Platforms. [PDF]

open access: yesPharmaceuticals (Basel)
Zhou Z   +9 more
europepmc   +1 more source

Profiling of HCAR1 signalling reveals Gαi/o and Gαs activation without β‐arrestin recruitment and the discovery of an allosteric agonist

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Lactate, historically viewed as a metabolic by‐product, has emerged as a signalling molecule via the G protein–coupled receptor Hydroxycarboxylic Acid Receptor 1 (HCAR1). The receptor is primarily expressed in adipocytes but also found in various other tissues.
Simon Lind   +6 more
wiley   +1 more source

A Study on the Mechanism of the Impact of Failed Learning on Enterprise Innovation Performance From the Perspective of Social Information Processing

open access: yesCreativity and Innovation Management, EarlyView.
ABSTRACT This study investigates the impact mechanism of different dimensions of failure learning on corporate innovation performance. Compared with the extensively researched field in the effects of organizational failure learning, this area remains largely underexplored.
Shiyuan Zhou, Yichao Si
wiley   +1 more source

Commentary: Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis. [PDF]

open access: yesFront Immunol
Tsai MC   +6 more
europepmc   +1 more source

Enteric Coating Enhances the Biopharmaceutical Performance of a Silica-Lipid Formulation of Abiraterone Acetate. [PDF]

open access: yesPharmaceutics
Taheri A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy